Organogenesis Holdings, Inc. Class A ORGO 深 滬
等待開盤 04-10 09:30:00 美东时间
2.295
-0.095
-3.97%
華盛通- 最 高2.425
- 今 開2.40
- 成交量 119.80万股
- 最 低 2.225
- 昨 收 2.39
- 總市值 2.96亿
- 52周最高 7.0771
- 市盈率 靜 14.93
- 換手率 0.93%
- 52周最低 2.21
- 委 比 4.64%
- 總股本 1.29亿
- 歷史最高 310.90
- 量 比 0.29
- 振 幅 8.37%
- 歷史最低 1.795
- 每 手 1
- 風險率 0.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Going On With Organogenesis Stock On Wednesday?
Organogenesis stock rises after PuraPly AM trial shows improved diabetic foot ulcer closure; RSI signals oversold levels amid weak trend.
04-08 22:15
美股夜盘 | Mawson Infrastructure Group Inc涨40.15%，Organogenesis Holdings, Inc. Class A涨29.46%
Mawson Infrastructure Group Inc涨40.15%；Organogenesis Holdings, Inc. Class A涨29.46%；Alignment Healthcare, Inc.涨15.85%
04-07 15:01
美股夜盘 | Mawson Infrastructure Group Inc涨42.86%，Organogenesis Holdings, Inc. Class A涨20.54%
Mawson Infrastructure Group Inc涨42.86%；Organogenesis Holdings, Inc. Class A涨20.54%；Alignment Healthcare, Inc.涨15.85%
04-07 13:01
美股夜盘 | Mawson Infrastructure Group Inc涨42.86%，Organogenesis Holdings, Inc. Class A涨18.75%
Mawson Infrastructure Group Inc涨42.86%；Organogenesis Holdings, Inc. Class A涨18.75%；Alignment Healthcare, Inc.涨15.85%
04-07 10:01
美股夜盘 | Mawson Infrastructure Group Inc涨36.29%，Organogenesis Holdings, Inc. Class A涨23.21%
Mawson Infrastructure Group Inc涨36.29%；Organogenesis Holdings, Inc. Class A涨23.21%；Alignment Healthcare, Inc.涨15.85%
04-07 09:01
美股夜盘 | Mawson Infrastructure Group Inc涨25.48%，Organogenesis Holdings, Inc. Class A涨21.88%
TNL Mediagene涨-13.83%；BeLive Holdings涨-9.06%；PMGC Holdings Inc.涨-8.33%
04-07 08:10
Organogenesis Holdings Completes Type-B Meeting With FDA And Plans to File BLA For ReNu Before The End Of December
Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports
04-07 05:37
美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
BTIG Reiterates Buy on Organogenesis Holdings, Maintains $8 Price Target
BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Buy and maintains $8 price target.
03-26 17:43
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
